ARTBIO: Funding, Investors & Team (Oct 2026)
ARTBIO is a company in the clinical stage of development that specializes in radiopharmaceutical biotechnology. They are dedicated to developing a novel category of alpha radioligand drugs that aim to revolutionize cancer treatment. ARTBIO is transforming the landscape of cancer care by introducing a new class of alpha radioligand therapeutics (ART) and the infrastructure to facilitate their use.
ARTBIO has raised $155M across 2 funding rounds on record, the most recent a Series B of $132M announced in Jul 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ARTBIO Company Profile and Key Stats
Latest funding round on record: Jul 2025.
ARTBIO Funding Rounds
ARTBIO raised $23.0M in a Seed announced in Jun 2023.
2.1 years later, a Series B of $132M was announced in Jul 2025.
ARTBIO Founders and Leadership Team
Contact details for the ARTBIO team: 1 of 2 have an email address on file.
Start 14-day free trial →ARTBIO Funding Compared to Other Biotechnology Startups
ARTBIO's latest round of $132M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ARTBIO in Biotechnology and Cambridge
Companies Similar to ARTBIO
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
ARTBIO Funding FAQs
What does ARTBIO do?
ARTBIO is a company in the clinical stage of development that specializes in radiopharmaceutical biotechnology. They are dedicated to developing a novel category of alpha radioligand drugs that aim to revolutionize cancer treatment. ARTBIO is transforming the landscape of cancer care by introducing a new class of alpha radioligand therapeutics (ART) and the infrastructure to facilitate their use.
How much funding has ARTBIO raised?
ARTBIO has raised $155M across 2 rounds on record. The most recent is a Series B of $132M announced in Jul 2025.
When did ARTBIO last raise funding?
ARTBIO's most recent funding round on record is a Series B of $132M, announced in Jul 2025.
Who founded ARTBIO?
FundedIQ lists Oyvind Sverre Bruland (Founder), Phil Ruis (Founder) at ARTBIO.
Where is ARTBIO headquartered?
ARTBIO is based in Cambridge, Massachusetts, United States.
How many employees does ARTBIO have?
ARTBIO is in the 51-100 employee band.
How does ARTBIO's funding compare to other Biotechnology startups?
ARTBIO's latest round of $132M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ARTBIO Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ARTBIO is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.